IP Library › Granted Patent US 10,983,111
Granted Patent B2
US 10,983,111 · App. 16/922,595 · Granted Apr 20, 2021

Human trophoblast stem cells and uses thereof

Inventors: Jau-Nan Lee (Kaohsiung, TW); Tony Tung-Ying Lee (Yakima, WA); Yuta Lee (Kaohsiung, TW)
Assignee: ACCELERATED BIOSCIENCES CORP.
G01N33/5073A61K35/39A61K35/54A61K39/395C12N5/0605C12N5/0606C12N5/0677A61K35/12C12N2500/34C12N2500/38C12N2500/44C12N2501/115C12N2506/02C12N2533/54
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,983,111
App. No.
16/922,595
Granted
Apr 20, 2021
Kind
B2
Abstract

Disclosed herein are human trophoblast stem (hTS) cells, differentiated cells thereof, derivatives thereof such as cellular mass, and uses thereof. The isolation of hTS cells can express FGF4, FGFR-2, Oct4, Thy-1, and stage-specific embryonic antigens distributed in different compartments of the cell. The hTS cells are able to derive into specific cell phenotypes of the three primitive embryonic layers, produce chimeric reactions in mice, and retain a normal karyotype and telomere length. In the hTS cells, Oct4 and fgfr-2 expressions can be knockdown by bFGF. The hTS cells could apply to human cell differentiation and for gene and cell-based therapies.

Claims (13)

1. A cellular mass, wherein the cellular mass comprises collagen embedded with human trophoblast stem cells and further comprises a mesodermal cell.

2. The cellular mass of claim 1 , wherein the human trophoblast stem cells express markers SSEA-1, SSEA-3, and SSEA-4.

3. The cellular mass of claim 1 , wherein the human trophoblast stem cells are induced to differentiate.

4. The cellular mass of claim 3 , wherein the cellular mass further comprises an endodermal cell.

5. The cellular mass of claim 3 , wherein the cellular mass further comprises an ectodermal cell.

6. The cellular mass of claim 1 , wherein the human trophoblast stem cells are induced to pancreatic β-islet like cells.

7. The cellular mass of claim 6 , wherein the pancreatic β-islet like cells secret insulin.

8. The cellular mass of claim 1 , wherein the collagen is present in a form of a matrix.

9. The cellular mass of claim 1 , wherein the cellular mass further comprises glucose.

10. The cellular mass of claim 1 , wherein at least some of the human trophoblast stem cells are penetrated into the collagen.

11. A cellular mass, wherein the cellular mass comprises collagen embedded with human trophoblast stem cells and further comprises pancreatic β-islet like cells capable of developing to a pancreatic tissue or organ.

12. A cellular mass, wherein the cellular mass comprises collagen embedded with human trophoblast stem cells, and wherein the collagen is in an acidic solution.

13. A cellular mass, wherein the cellular mass comprises collagen embedded with human trophoblast stem cells, and wherein at least some of the human trophoblast stem cells are present in a flat, umbrella-like layer on the collagen.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2020
From: LEE, JAU-NAN; LEE, TONY TUNG-YING; LEE, YUTA
To: ACCELERATED BIOSCIENCES CORP.
Reel/Frame 053152/0430 →
Continuity (9)
Continuation 15892777 · Feb 9, 2018
Division 14840970 · Aug 31, 2015
Continuation 13909469 · Jun 4, 2013
Division 13415595 · Mar 8, 2012
Division 12972237 · Dec 17, 2010
Division 12405112 · Mar 16, 2009
Division 11361588 · Feb 24, 2006
Provisional Application 60655747 · Feb 24, 2005
Related Publication 20200333326A1 · Oct 22, 2020